Although the comparison of agonist activity against GPER with E2 was not evaluated in this study and requires further investigation, the fact that PIC was shown to have an anti-obesity effect via GPER suggests that PIC may be beneficial as an alternative treatment for obesity to ERT. Here, GPER1 is linked to obesity disorder.